PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE ULCERATIVE COLITIS PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY

Bernd Bokemeyer  ¹     Sandra Plachta-Danielzik  ²     Romina di Giuseppe  ²     Philipp Efken  ³     Wolfgang Mohl  ⁴     Thomas Krause  ⁵     Martin Hoffstadt  ⁶     Robert Ehehalt  ⁷     Leo Trentmann  ⁸     Axel Schweitzer  ⁹     Petra Jessen  ¹⁰     Sina Franzenburg  ¹⁰     Petra Hartmann  ¹⁰     Stefan Schreiber  ^11    
1 Interdisciplinary Crohn Colitis Centre Minden, Minden, Germany
² Competence Network IBD, Kiel, Germany
³ Gastroenterology Practice Minden, Minden, Germany
⁴ Zentrum fur Gastroenterologie Saar MVZ GmbH, Saarbrücken, Germany
⁵ Gastroenterology Practice Opernstraße, Kassel, Germany
⁶ Medizinisches Versorgungszentrum Dres. Hoffstadt, Iserlohn, Germany
⁷ Praxis für Gastroenterologie Prof. Dr. R. Ehehalt, Heidelberg, Germany
⁸ Gastroenterology Practice Bremen, Bremen, Germany
⁹ Gastroenterologische Gemeinschaftspraxis am Germania Campus, Münster, Germany
¹⁰ Gastroenterology Practice Kiel, Altenholz, Germany
¹¹ Universität Kiel UKSH Medizinische Abt. I, Kiel, Germany

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)